Performance evaluation of a novel high-sensitivity cardiac troponin T assay: analytical and clinical perspectives
Clinical Chemistry and Laboratory Medicine (CCLM) · 2024
DOI: 10.1515/cclm-2023-0789 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Chemistry and Laboratory Medicine (CCLM), 2024. Verfasst von Zhongxin Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Peking University Third Hospital, Beijing, P.R. China. Hauptthemen laut MEDLINE: Myocardial Infarction, Non-ST Elevated Myocardial Infarction, ST Elevation Myocardial Infarction. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: Key Clinical Specialty Funding Project of Beijing, National Key Research and Development Program of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
Objectives
To evaluate the analytical characteristics of a novel high-sensitivity cardiac troponin T (hs-cTnT) test on the automatic light-initiated chemiluminescent assay (LiCA ® ) system, and validated its diagnostic performance for non-ST-segment elevation myocardial infarction (NSTEMI).
Methods
Studies included an extensive analytical evaluation and established the 99th percentile upper reference limit (URL) from apparently healthy individuals, followed by a diagnostic performance validation for NSTEMI.
Results
Sex-specific 99th percentile URLs were 16.0 ng/L (1.7 % CV: coefficient of variation) for men (21–92 years) and 13.4 ng/L (2.0 % CV) for women (23–87 years) in serum, and 30.6 ng/L (0.9 % CV) for men (18–87 years) and 20.2 ng/L (1.4 % CV) for women (18–88 years) in heparin plasma. Detection rates in healthy individuals ranged from 98.9 to 100 %. An excellent agreement was identified between LiCA ® and Elecsys ® assays with a correlation coefficient of 0.993 and mean bias of −0.7 % (−1.8–0.4 %) across the full measuring range, while the correlation coefficient and overall bias were 0.967 and −1.1 % (−2.5–0.3 %) for the lower levels of cTnT (10–100 ng/L), respectively. At the specific medical decision levels (14.0 and 52.0 ng/L), assay difference was estimated to be
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine, Peking University Third Hospital, Beijing, P.R. China.
Förderung
- Key Clinical Specialty Funding Project of Beijing
- National Key Research and Development Program of China
- National Natural Science Foundation of China
Zitieren
APA
Li, Z., Yang, S., Qiao, J., Tan, Y., Liu, Q., Yang, B., Feng, W., & Cui, L. (2024). Performance evaluation of a novel high-sensitivity cardiac troponin T assay: analytical and clinical perspectives. Clinical Chemistry and Laboratory Medicine (CCLM). https://doi.org/10.1515/cclm-2023-0789
Vancouver
Li Z, Yang S, Qiao J, Tan Y, Liu Q, Yang B, et al. Performance evaluation of a novel high-sensitivity cardiac troponin T assay: analytical and clinical perspectives. Clinical Chemistry and Laboratory Medicine (CCLM). 2024. doi:10.1515/cclm-2023-0789
BibTeX
@article{Li2024,
author = {Li, Zhongxin and Yang, Shuo and Qiao, Jiao and Tan, Yuan and Liu, Qi and Yang, Boxin and Feng, Weimin and Cui, Liyan},
title = {Performance evaluation of a novel high-sensitivity cardiac troponin T assay: analytical and clinical perspectives},
journal = {Clinical Chemistry and Laboratory Medicine (CCLM)},
year = {2024},
doi = {10.1515/cclm-2023-0789}
}
EUVIMED